Natalie Lumsden

997 total citations
29 papers, 642 citations indexed

About

Natalie Lumsden is a scholar working on Molecular Biology, General Health Professions and Genetics. According to data from OpenAlex, Natalie Lumsden has authored 29 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in General Health Professions and 6 papers in Genetics. Recurrent topics in Natalie Lumsden's work include Nicotinic Acetylcholine Receptors Study (10 papers), Venomous Animal Envenomation and Studies (6 papers) and Ion channel regulation and function (5 papers). Natalie Lumsden is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (10 papers), Venomous Animal Envenomation and Studies (6 papers) and Ion channel regulation and function (5 papers). Natalie Lumsden collaborates with scholars based in Australia, Singapore and Chile. Natalie Lumsden's co-authors include Wayne C. Hodgson, R. Manjunatha Kini, Bryan G. Fry, Rayomand S. Khambata, Adrian J. Hobbs, Richard J. Lewis, Janith C. Wickramaratna, Paul F. Alewood, Sébastien Dutertre and Sabatino Ventura and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Natalie Lumsden

28 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natalie Lumsden Australia 15 325 240 95 95 69 29 642
Neville Marsh United Kingdom 12 183 0.6× 325 1.4× 61 0.6× 112 1.2× 106 1.5× 18 667
Martin Ebbecke Germany 10 199 0.6× 58 0.2× 29 0.3× 35 0.4× 27 0.4× 14 445
Juliano R. Guerreiro Brazil 10 264 0.8× 228 0.9× 47 0.5× 21 0.2× 32 0.5× 15 426
Sabine Lutz‐Bonengel Germany 18 756 2.3× 435 1.8× 16 0.2× 6 0.1× 31 0.4× 42 1.1k
William R. Welches United States 8 390 1.2× 203 0.8× 216 2.3× 27 0.3× 55 0.8× 9 655
Mussa Ali United States 5 463 1.4× 35 0.1× 22 0.2× 40 0.4× 38 0.6× 5 705
Laura Monti Italy 16 333 1.0× 55 0.2× 6 0.1× 70 0.7× 35 0.5× 33 584
А. Н. Мурашев Russia 13 284 0.9× 64 0.3× 36 0.4× 16 0.2× 86 1.2× 48 512
Lisa Misell United States 10 283 0.9× 56 0.2× 20 0.2× 18 0.2× 170 2.5× 15 714
RL Smith United Kingdom 11 184 0.6× 58 0.2× 12 0.1× 22 0.2× 19 0.3× 21 521

Countries citing papers authored by Natalie Lumsden

Since Specialization
Citations

This map shows the geographic impact of Natalie Lumsden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Lumsden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Lumsden more than expected).

Fields of papers citing papers by Natalie Lumsden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Lumsden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Lumsden. The network helps show where Natalie Lumsden may publish in the future.

Co-authorship network of co-authors of Natalie Lumsden

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Lumsden. A scholar is included among the top collaborators of Natalie Lumsden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Lumsden. Natalie Lumsden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hunter, Barbara, Sandra Davidson, Natalie Lumsden, et al.. (2024). Optimising a clinical decision support tool to improve chronic kidney disease management in general practice. BMC Primary Care. 25(1). 220–220. 5 indexed citations
2.
3.
Martínez-Gutiérrez, Javiera, Barbara Hunter, Patty Chondros, et al.. (2024). Future Health Today and patients at risk of undiagnosed cancer: a pragmatic cluster randomised trial of quality- improvement activities in general practice. British Journal of General Practice. 75(754). e306–e315. 1 indexed citations
4.
Manski‐Nankervis, Jo‐Anne, et al.. (2024). Implementing a Sodium-Glucose Cotransporter 2 Inhibitor Module With a Software Tool (Future Health Today): Qualitative Study. JMIR Formative Research. 8. e50737–e50737. 2 indexed citations
5.
Manski‐Nankervis, Jo‐Anne, Karyn Alexander, Ruby Biezen, et al.. (2021). Towards optimising chronic kidney disease detection and management in primary care: Underlying theory and protocol for technology development using an Integrated Knowledge Translation approach. Health Informatics Journal. 27(2). 1187493603–1187493603. 4 indexed citations
6.
Michell, Danielle L., Waled Shihata, Karen L. Andrews, et al.. (2021). High intraluminal pressure promotes vascular inflammation via caveolin-1. Scientific Reports. 11(1). 5894–5894. 9 indexed citations
7.
Hunter, Barbara, Ruby Biezen, Karyn Alexander, et al.. (2020). Future Health Today: codesign of an electronic chronic disease quality improvement tool for use in general practice using a service design approach. BMJ Open. 10(12). e040228–e040228. 15 indexed citations
8.
9.
Woollard, Kevin, Natalie Lumsden, Karen L. Andrews, et al.. (2014). Raised Soluble P-Selectin Moderately Accelerates Atherosclerotic Plaque Progression. PLoS ONE. 9(5). e97422–e97422. 17 indexed citations
10.
Suzuki, Satoshi, Miklós Lipcsey, Natalie Lumsden, et al.. (2013). Near-infrared spectroscopy of the thenar eminence to estimate forearm blood flow. Critical Care and Resuscitation. 15(4). 323–326. 3 indexed citations
11.
Lumsden, Natalie, Rayomand S. Khambata, & Adrian J. Hobbs. (2010). C-type Natriuretic Peptide (CNP): Cardiovascular Roles and Potential as a Therapeutic Target. Current Pharmaceutical Design. 16(37). 4080–4088. 73 indexed citations
12.
Duggan, Peter J., et al.. (2009). Low molecular weight non-peptide mimics of ω-conotoxin GVIA. Bioorganic & Medicinal Chemistry Letters. 19(10). 2763–2765. 22 indexed citations
13.
Andersson, Åsa, Jonathan B. Baell, Peter J. Duggan, et al.. (2009). ω-Conotoxin GVIA mimetics based on an anthranilamide core: Effect of variation in ammonium side chain lengths and incorporation of fluorine. Bioorganic & Medicinal Chemistry. 17(18). 6659–6670. 15 indexed citations
14.
Duggan, Peter J., et al.. (2008). Synthesis and Cav2.2 Binding Data for Non-Peptide Mimetics of ?-Conotoxin GVIA based on a 5-Amino-Anthranilamide Core. Australian Journal of Chemistry. 61(1). 11–15. 6 indexed citations
15.
Dutertre, Sébastien, Daniel E. Croker, Norelle L. Daly, et al.. (2008). Conopressin-T from Conus tulipa Reveals an Antagonist Switch in Vasopressin-like Peptides. Journal of Biological Chemistry. 283(11). 7100–7108. 71 indexed citations
16.
Dutertre, Sébastien, Natalie Lumsden, Paul F. Alewood, & Richard J. Lewis. (2006). Isolation and characterisation of conomap‐Vt, a d‐amino acid containing excitatory peptide from the venom of a vermivorous cone snail. FEBS Letters. 580(16). 3860–3866. 39 indexed citations
17.
Lumsden, Natalie, Bryan G. Fry, Sabatino Ventura, R. Manjunatha Kini, & Wayne C. Hodgson. (2005). Pharmacological characterisation of a neurotoxin from the venom of Boiga dendrophila (Mangrove catsnake). Toxicon. 45(3). 329–334. 45 indexed citations
18.
Lumsden, Natalie, Bryan G. Fry, R. Manjunatha Kini, & Wayne C. Hodgson. (2004). In vitro neuromuscular activity of ‘colubrid’ venoms: clinical and evolutionary implications. Toxicon. 43(7). 819–827. 25 indexed citations
19.
Lumsden, Natalie, et al.. (2004). A biochemical and pharmacological examination of Rhamphiophis oxyrhynchus (Rufous beaked snake) venom. Toxicon. 45(2). 219–231. 9 indexed citations
20.
Fry, Bryan G., et al.. (2003). Isolation of a Neurotoxin (?-colubritoxin) from a Nonvenomous Colubrid: Evidence for Early Origin of Venom in Snakes. Journal of Molecular Evolution. 57(4). 446–452. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neville Marsh Breakdown of academic impact, for papers by Martin Ebbecke Breakdown of academic impact, for papers by Juliano R. Guerreiro Breakdown of academic impact, for papers by Sabine Lutz‐Bonengel Breakdown of academic impact, for papers by William R. Welches Breakdown of academic impact, for papers by Mussa Ali Breakdown of academic impact, for papers by Laura Monti Breakdown of academic impact, for papers by А. Н. Мурашев Breakdown of academic impact, for papers by Lisa Misell Breakdown of academic impact, for papers by RL Smith
Rankless by CCL
2026